Insider Trading Alert - NATI, MDCO, NBL, KBR And LNG Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 4, 2013, 189 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $160.56 to $35,901,027,172.20.

Highlighted Stocks Traded by Insiders:

National Instruments Corporation (NATI) - FREE Research Report

Kodosky Jeffrey L who is Director at National Instruments Corporation sold 12,000 shares at $31.35 on Dec. 4, 2013. Following this transaction, the Director owned 983,180 shares meaning that the stake was reduced by 1.21% with the 12,000-share transaction.

The shares most recently traded at $30.07, down $1.28, or 4.25% since the insider transaction. Historical insider transactions for National Instruments Corporation go as follows:

  • 4-Week # shares sold: 17,271
  • 12-Week # shares sold: 49,271
  • 24-Week # shares sold: 101,271

The average volume for National Instruments Corporation has been 401,200 shares per day over the past 30 days. National Instruments Corporation has a market cap of $3.8 billion and is part of the technology sector and computer software & services industry. Shares are up 17.98% year-to-date as of the close of trading on Wednesday.

National Instruments Corporation designs, manufactures, and sells tools to engineers and scientists worldwide. It offers LabVIEW, a system design software product for measurement and control; and LabVIEW Real-Time and LabVIEW FPGA that are strategic modular software add-ons. The stock currently has a dividend yield of 1.84%. The company has a P/E ratio of 55.4. Currently there is 1 analyst that rates National Instruments Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NATI - FREE

TheStreet Quant Ratings rates National Instruments Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full National Instruments Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medicines (MDCO) - FREE Research Report

Meanwell Clive who is Chairman & CEO at Medicines sold 10,000 shares at $36.58 on Dec. 4, 2013. Following this transaction, the Chairman & CEO owned 307,773 shares meaning that the stake was reduced by 3.15% with the 10,000-share transaction.

The shares most recently traded at $38.44, up $1.86, or 4.85% since the insider transaction. Historical insider transactions for Medicines go as follows:

  • 4-Week # shares sold: 11,667
  • 12-Week # shares sold: 20,635
  • 24-Week # shares sold: 43,135

The average volume for Medicines has been 853,900 shares per day over the past 30 days. Medicines has a market cap of $2.3 billion and is part of the health care sector and drugs industry. Shares are up 57.28% year-to-date as of the close of trading on Wednesday.

The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company has a P/E ratio of 59.0. Currently there are 5 analysts that rate Medicines a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDCO - FREE

TheStreet Quant Ratings rates Medicines as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Medicines Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Noble Energy (NBL) - FREE Research Report

Fisher Kenneth M. who is Exec. VP & CFO at Noble Energy sold 15,490 shares at $70.04 on Dec. 4, 2013. Following this transaction, the Exec. VP & CFO owned 116,170 shares meaning that the stake was reduced by 11.77% with the 15,490-share transaction.

The shares most recently traded at $69.30, down $0.74, or 1.07% since the insider transaction. Historical insider transactions for Noble Energy go as follows:

  • 4-Week # shares sold: 4,700
  • 12-Week # shares sold: 9,700
  • 24-Week # shares sold: 14,700

The average volume for Noble Energy has been 1.9 million shares per day over the past 30 days. Noble Energy has a market cap of $25.0 billion and is part of the basic materials sector and energy industry. Shares are up 36.9% year-to-date as of the close of trading on Wednesday.

Noble Energy, Inc., an independent energy company, engages in the acquisition, exploration, development, production, and marketing of crude oil, natural gas, and natural gas liquids primarily in the United States, West Africa, and Eastern Mediterranean. The stock currently has a dividend yield of 0.81%. The company has a P/E ratio of 23.6. Currently there are 12 analysts that rate Noble Energy a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NBL - FREE

TheStreet Quant Ratings rates Noble Energy as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, solid stock price performance, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Noble Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

KBR (KBR) - FREE Research Report

Utt William P who is CEO and President at KBR sold 8,703 shares at $33.50 on Dec. 4, 2013. Following this transaction, the CEO and President owned 43,523 shares meaning that the stake was reduced by 16.66% with the 8,703-share transaction.

The shares most recently traded at $33.22, down $0.28, or 0.84% since the insider transaction. Historical insider transactions for KBR go as follows:

  • 4-Week # shares sold: 8,703
  • 12-Week # shares sold: 17,406
  • 24-Week # shares sold: 43,515

The average volume for KBR has been 1.5 million shares per day over the past 30 days. KBR has a market cap of $4.9 billion and is part of the services sector and diversified services industry. Shares are up 11.43% year-to-date as of the close of trading on Wednesday.

KBR, Inc. operates as an engineering, construction, and services company worldwide. The stock currently has a dividend yield of 0.96%. The company has a P/E ratio of 21.2. Currently there are 8 analysts that rate KBR a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KBR - FREE

TheStreet Quant Ratings rates KBR as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full KBR Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cheniere Energy (LNG) - FREE Research Report

Souki Charif who is Chairman, CEO & President at Cheniere Energy sold 30,000 shares at $39.17 on Dec. 4, 2013. Following this transaction, the Chairman, CEO & President owned 7.2 million shares meaning that the stake was reduced by 0.41% with the 30,000-share transaction.

Thames Howard Davis who is Sr. VP & CFO at Cheniere Energy sold 10,000 shares at $39.54 on Dec. 4, 2013. Following this transaction, the Sr. VP & CFO owned 1.4 million shares meaning that the stake was reduced by 0.69% with the 10,000-share transaction.

The shares most recently traded at $43.72, up $4.18, or 9.56% since the insider transaction. Historical insider transactions for Cheniere Energy go as follows:

  • 4-Week # shares sold: 26,500
  • 12-Week # shares sold: 209,500
  • 24-Week # shares sold: 457,500

The average volume for Cheniere Energy has been 3.7 million shares per day over the past 30 days. Cheniere Energy has a market cap of $9.9 billion and is part of the basic materials sector and energy industry. Shares are up 120.39% year-to-date as of the close of trading on Wednesday.

Cheniere Energy, Inc., an energy company, engages in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business. Currently there are 4 analysts that rate Cheniere Energy a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNG - FREE

TheStreet Quant Ratings rates Cheniere Energy as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Cheniere Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

National Instruments Has More Room on the Upside

National Instruments Has More Room on the Upside

21 Buzzwords That Goldman Sachs Thinks All Investors Should Know Now

21 Buzzwords That Goldman Sachs Thinks All Investors Should Know Now

Insiders Are Scooping Up These 5 Stocks Right Now

Insiders Are Scooping Up These 5 Stocks Right Now

Insider Trading Alert - NATI, PCLN And LQ Traded By Insiders

Insider Trading Alert - NATI, PCLN And LQ Traded By Insiders

Trifecta Stocks: Concerns Rise Amid Weak GDP Forecast, So-So Store Sales

Trifecta Stocks: Concerns Rise Amid Weak GDP Forecast, So-So Store Sales